 | • レポートコード：20QY06-03822 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、ポリオワクチンのグローバル市場について種類別（不活化ポリオワクチン（IPV）、経口ポリオワクチン（OPV））、用途別（パブリック、プライベート）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ポリオワクチン市場の概要 ・世界の主要地域別ポリオワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のポリオワクチン市場規模2015-2026：種類別（不活化ポリオワクチン（IPV）、経口ポリオワクチン（OPV）） ・世界のポリオワクチン市場規模2015-2026：用途別（パブリック、プライベート） ・ポリオワクチンの北米市場規模2015-2020 ・ポリオワクチンのヨーロッパ市場規模2015-2020 ・ポリオワクチンの中国市場規模2015-2020 ・ポリオワクチンの日本市場規模2015-2020 ・ポリオワクチンの東南アジア市場規模2015-2020 ・ポリオワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Sanofi、GSK、Bibcol、Serum Institute、Tiantan Biological、IMBCA、Panacea Biotec Ltd、Bio-Med、Halfkin Bio-Pharmaceuticals） ・ポリオワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ポリオワクチンの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Polio Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Polio Vaccine market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Polio Vaccine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Polio Vaccine industry.
Based on our recent survey, we have several different scenarios about the Polio Vaccine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 1351.8 million in 2019. The market size of Polio Vaccine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Polio Vaccine market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Polio Vaccine market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Polio Vaccine market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Polio Vaccine market. The report also includes nautical information, where it shows Polio Vaccine market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Polio Vaccine market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Polio Vaccine market.
The global average price of Polio Vaccine is in the increasing trend, from 497 USD/K doses in 2012 to 534 USD/K doses in 2016. With the situation of global economy and the IPV more and more popular, prices will be in increasing trend in the following five years.
Geographical Analysis:
Based on region, the global Polio Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Polio Vaccine market are
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Segment by Application
Public
Private
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Polio Vaccine market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Polio Vaccine market.
• The market share of the global Polio Vaccine market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Polio Vaccine market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Polio Vaccine market.
1 Polio Vaccine Market Overview
1.1 Polio Vaccine Product Scope
1.2 Polio Vaccine Segment by Type
1.2.1 Global Polio Vaccine Sales by Type (2020-2026)
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Polio Vaccine Segment by Application
1.3.1 Global Polio Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Public
1.3.3 Private
1.4 Polio Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Polio Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Polio Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Polio Vaccine Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Polio Vaccine Industry Impact
1.5.1 How the Covid-19 is Affecting the Polio Vaccine Industry
1.5.1.1 Polio Vaccine Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Polio Vaccine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Polio Vaccine Players to Combat Covid-19 Impact
2 Polio Vaccine Estimate and Forecast by Region
2.1 Global Polio Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Polio Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Polio Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Polio Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Polio Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Polio Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Polio Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Polio Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Polio Vaccine Estimates and Projections (2015-2026)
2.4.3 China Polio Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Polio Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Polio Vaccine Estimates and Projections (2015-2026)
2.4.6 India Polio Vaccine Estimates and Projections (2015-2026)
3 Global Polio Vaccine Competition Landscape by Players
3.1 Global Top Polio Vaccine Players by Sales (2015-2020)
3.2 Global Top Polio Vaccine Players by Revenue (2015-2020)
3.3 Global Polio Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polio Vaccine as of 2019)
3.4 Global Polio Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Polio Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Polio Vaccine Players (Opinion Leaders)
4 Global Polio Vaccine Market Size by Type
4.1 Global Polio Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Polio Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Polio Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Polio Vaccine Price by Type (2014-2020)
4.2 Global Polio Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Polio Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Polio Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Polio Vaccine Price Forecast by Type (2021-2026)
5 Global Polio Vaccine Market Size by Application
5.1 Global Polio Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Polio Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Polio Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Polio Vaccine Price by Application (2015-2020)
5.2 Global Polio Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Polio Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Polio Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Polio Vaccine Price Forecast by Application (2021-2026)
3 North America Polio Vaccine Market Facts & Figures
3.2 North America Polio Vaccine Sales Market Share by Company (2015-2020)
3.3 North America Polio Vaccine Sales Market Share by Type (2015-2020)
3.4 North America Polio Vaccine Sales Market Share by Application (2015-2020)
4 Europe Polio Vaccine Market Facts & Figures
4.2 Europe Polio Vaccine Sales Market Share by Company (2015-2020)
4.3 Europe Polio Vaccine Sales Market Share by Type (2015-2020)
4.4 Europe Polio Vaccine Sales Market Share by Application (2015-2020)
5 China Polio Vaccine Market Facts & Figures
5.2 China Polio Vaccine Sales Market Share by Company (2015-2020)
5.3 China Polio Vaccine Sales Market Share by Type (2015-2020)
5.4 China Polio Vaccine Sales Market Share by Application (2015-2020)
6 Japan Polio Vaccine Market Facts & Figures
6.2 Japan Polio Vaccine Sales Market Share by Company (2015-2020)
6.3 Japan Polio Vaccine Sales Market Share by Type (2015-2020)
6.4 Japan Polio Vaccine Sales Market Share by Application (2015-2020)
7 Southeast Asia Polio Vaccine Market Facts & Figures
7.2 Southeast Asia Polio Vaccine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Polio Vaccine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Polio Vaccine Sales Market Share by Application (2015-2020)
8 India Polio Vaccine Market Facts & Figures
8.2 India Polio Vaccine Sales Market Share by Company (2015-2020)
8.3 India Polio Vaccine Sales Market Share by Type (2015-2020)
8.4 India Polio Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Polio Vaccine Business
12.1 Sanofi
12.1.1 Sanofi Polio Vaccine Corporation Information
12.1.2 Sanofi Polio Vaccine Business Overview and Total Revenue
12.1.3 Sanofi Polio Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Sanofi Polio Vaccine Products Offered
12.1.5 Sanofi Recent Development
12.2 GSK
12.2.1 GSK Polio Vaccine Corporation Information
12.2.2 GSK Polio Vaccine Business Overview and Total Revenue
12.2.3 GSK Polio Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GSK Polio Vaccine Products Offered
12.2.5 GSK Recent Development
12.3 Bibcol
12.3.1 Bibcol Polio Vaccine Corporation Information
12.3.2 Bibcol Polio Vaccine Business Overview and Total Revenue
12.3.3 Bibcol Polio Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Bibcol Polio Vaccine Products Offered
12.3.5 Bibcol Recent Development
12.4 Serum Institute
12.4.1 Serum Institute Polio Vaccine Corporation Information
12.4.2 Serum Institute Polio Vaccine Business Overview and Total Revenue
12.4.3 Serum Institute Polio Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Serum Institute Polio Vaccine Products Offered
12.4.5 Serum Institute Recent Development
12.5 Tiantan Biological
12.5.1 Tiantan Biological Polio Vaccine Corporation Information
12.5.2 Tiantan Biological Polio Vaccine Business Overview and Total Revenue
12.5.3 Tiantan Biological Polio Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Tiantan Biological Polio Vaccine Products Offered
12.5.5 Tiantan Biological Recent Development
12.6 IMBCA
12.6.1 IMBCA Polio Vaccine Corporation Information
12.6.2 IMBCA Polio Vaccine Business Overview and Total Revenue
12.6.3 IMBCA Polio Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 IMBCA Polio Vaccine Products Offered
12.6.5 IMBCA Recent Development
12.7 Panacea Biotec Ltd
12.7.1 Panacea Biotec Ltd Polio Vaccine Corporation Information
12.7.2 Panacea Biotec Ltd Polio Vaccine Business Overview and Total Revenue
12.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Panacea Biotec Ltd Polio Vaccine Products Offered
12.7.5 Panacea Biotec Ltd Recent Development
12.8 Bio-Med
12.8.1 Bio-Med Polio Vaccine Corporation Information
12.8.2 Bio-Med Polio Vaccine Business Overview and Total Revenue
12.8.3 Bio-Med Polio Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Bio-Med Polio Vaccine Products Offered
12.8.5 Bio-Med Recent Development
12.9 Halfkin Bio-Pharmaceuticals
12.9.1 Halfkin Bio-Pharmaceuticals Polio Vaccine Corporation Information
12.9.2 Halfkin Bio-Pharmaceuticals Polio Vaccine Business Overview and Total Revenue
12.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Products Offered
12.9.5 Halfkin Bio-Pharmaceuticals Recent Development
13 Polio Vaccine Manufacturing Cost Analysis
13.1 Polio Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Polio Vaccine
13.4 Polio Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Polio Vaccine Distributors List
14.3 Polio Vaccine Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Polio Vaccine Sales (M Doses) Growth Rate by Type (2020-2026)
Table 2. Global Polio Vaccine Sales (M Doses) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Polio Vaccine Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Polio Vaccine Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Polio Vaccine Players to Combat Covid-19 Impact
Table 8. Global Market Polio Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Polio Vaccine Sales (M Doses) by Region (2015-2020)
Table 10. Global Polio Vaccine Sales Market Share by Region (2015-2020)
Table 11. Global Polio Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Polio Vaccine Revenue Share by Region (2015-2020)
Table 13. Global Polio Vaccine Sales (M Doses) Forecast by Region (2021-2026)
Table 14. Global Polio Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Polio Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Polio Vaccine Revenue Share Forecast by Region (2021-2026)
Table 17. Global Polio Vaccine (M Doses) of Key Companies (2015-2020)
Table 18. Global Polio Vaccine Sales Share by Company (2015-2020)
Table 19. Global Polio Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Polio Vaccine Revenue Share by Company (2015-2020)
Table 21. Global Polio Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polio Vaccine as of 2019)
Table 22. Global Polio Vaccine Average Price (USD/K Doses) of Key Company (2015-2020)
Table 23. Manufacturers Polio Vaccine Manufacturing Sites and Area Served
Table 24. Manufacturers Polio Vaccine Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Polio Vaccine Players
Table 27. Global Polio Vaccine Sales (M Doses) by Type (2015-2020)
Table 28. Global Polio Vaccine Sales Share by Type (2015-2020)
Table 29. Global Polio Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Polio Vaccine Price (M Doses) by Type (2015-2020)
Table 31. Global Polio Vaccine Sales Share by Type (2021-2026)
Table 32. Global Polio Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Polio Vaccine Revenue Share by Type (2021-2026)
Table 34. Global Polio Vaccine Price (M Doses) by Type (2021-2026)
Table 35. Global Polio Vaccine Sales (M Doses) by Application (2015-2020)
Table 36. Global Polio Vaccine Sales Share by Application (2015-2020)
Table 37. Global Polio Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Polio Vaccine Price (M Doses) by Application (2015-2020)
Table 39. Global Polio Vaccine Sales (M Doses) by Application (2021-2026)
Table 40. Global Polio Vaccine Sales Share by Application (2021-2026)
Table 41. Global Polio Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Polio Vaccine Revenue Share by Application (2021-2026)
Table 43. Global Polio Vaccine Price (M Doses) by Application (2021-2026)
Table 44. United States Polio Vaccine Sales (M Doses) by Company (2015-2020)
Table 45. United States Polio Vaccine Sales Market Share by Company (2015-2020)
Table 46. United States Polio Vaccine Sales (M Doses) by Type (2015-2020)
Table 47. United States Polio Vaccine Sales Market Share by Type (2015-2020)
Table 48. United States Polio Vaccine Sales (M Doses) by Application (2015-2020)
Table 49. United States Polio Vaccine Sales Market Share by Application (2015-2020)
Table 50. Europe Polio Vaccine Sales (M Doses) by Company (2015-2020)
Table 51. Europe Polio Vaccine Sales Market Share by Company (2015-2020)
Table 52. Europe Polio Vaccine Sales (M Doses) by Type (2015-2020)
Table 53. Europe Polio Vaccine Sales Market Share by Type (2015-2020)
Table 54. Europe Polio Vaccine Sales (M Doses) by Application (2015-2020)
Table 55. Europe Polio Vaccine Sales Market Share by Type (2015-2020)
Table 56. China Polio Vaccine Sales (M Doses) by Company (2015-2020)
Table 57. China Polio Vaccine Sales Market Share by Company (2015-2020)
Table 58. China Polio Vaccine Sales (M Doses) by Type (2015-2020)
Table 59. China Polio Vaccine Sales Market Share by Type (2015-2020)
Table 60. China Polio Vaccine Sales (M Doses) by Application (2015-2020)
Table 61. China Polio Vaccine Sales Market Share by Application (2015-2020)
Table 62. Japan Polio Vaccine Sales (M Doses) by Company (2015-2020)
Table 63. Japan Polio Vaccine Sales Market Share by Company (2015-2020)
Table 64. Japan Polio Vaccine Sales (M Doses) by Type (2015-2020)
Table 65. Japan Polio Vaccine Sales Market Share by Type (2015-2020)
Table 66. Japan Polio Vaccine Sales (M Doses) by Application (2015-2020)
Table 67. Japan Polio Vaccine Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Polio Vaccine Sales (M Doses) by Company (2015-2020)
Table 69. Southeast Asia Polio Vaccine Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Polio Vaccine Sales (M Doses) by Type (2015-2020)
Table 71. Southeast Asia Polio Vaccine Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Polio Vaccine Sales (M Doses) by Type (2015-2020)
Table 73. Southeast Asia Polio Vaccine Sales Market Share by Application (2015-2020)
Table 74. India Polio Vaccine Sales (M Doses) by Company (2015-2020)
Table 75. India Polio Vaccine Sales Market Share by Company (2015-2020)
Table 76. India Polio Vaccine Sales (M Doses) by Type (2015-2020)
Table 77. India Polio Vaccine Sales Market Share by Type (2015-2020)
Table 78. India Polio Vaccine Sales (M Doses) by Application (2015-2020)
Table 79. India Polio Vaccine Sales Market Share by Application (2015-2020)
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Polio Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 83. Sanofi Polio Vaccine Product
Table 84. Sanofi Recent Development
Table 85. GSK Corporation Information
Table 86. GSK Description and Business Overview
Table 87. GSK Polio Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 88. GSK Polio Vaccine Product
Table 89. GSK Recent Development
Table 90. Bibcol Corporation Information
Table 91. Bibcol Description and Business Overview
Table 92. Bibcol Polio Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 93. Bibcol Polio Vaccine Product
Table 94. Bibcol Recent Development
Table 95. Serum Institute Corporation Information
Table 96. Serum Institute Description and Business Overview
Table 97. Serum Institute Polio Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 98. Serum Institute Polio Vaccine Product
Table 99. Serum Institute Recent Development
Table 100. Tiantan Biological Corporation Information
Table 101. Tiantan Biological Description and Business Overview
Table 102. Tiantan Biological Polio Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 103. Tiantan Biological Polio Vaccine Product
Table 104. Tiantan Biological Recent Development
Table 105. IMBCA Corporation Information
Table 106. IMBCA Description and Business Overview
Table 107. IMBCA Polio Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 108. IMBCA Polio Vaccine Product
Table 109. IMBCA Recent Development
Table 110. Panacea Biotec Ltd Corporation Information
Table 111. Panacea Biotec Ltd Description and Business Overview
Table 112. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 113. Panacea Biotec Ltd Polio Vaccine Product
Table 114. Panacea Biotec Ltd Recent Development
Table 115. Bio-Med Corporation Information
Table 116. Bio-Med Polio Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 117. Bio-Med Description and Business Overview
Table 118. Bio-Med Polio Vaccine Product
Table 119. Bio-Med Recent Development
Table . Halfkin Bio-Pharmaceuticals Corporation Information
Table . Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table . Halfkin Bio-Pharmaceuticals Description and Business Overview
Table . Halfkin Bio-Pharmaceuticals Polio Vaccine Product
Table . Halfkin Bio-Pharmaceuticals Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Polio Vaccine Distributors List
Table 128. Polio Vaccine Customers List
Table 129. Market Key Trends
Table 130. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 131. Key Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Polio Vaccine Product Picture
Figure 2. Global Polio Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Polio Vaccine Market Share by Application in 2020 & 2026
Figure 6. Public Examples
Figure 7. Private Examples
Figure 8. Global Polio Vaccine Sales (M Doses) Growth Rate (2015-2026)
Figure 9. Global Polio Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Polio Vaccine Price Trends Growth Rate (2015-2026) (USD/K Doses)
Figure 11. Global Polio Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Polio Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Polio Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Polio Vaccine Sales (M Doses) Growth Rate (2015-2026)
Figure 15. Europe Polio Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Polio Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Polio Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Polio Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Polio Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Polio Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Polio Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Polio Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Polio Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Polio Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Polio Vaccine Players Market Share by Revenue in Polio Vaccine 2015 & 2019
Figure 26. Polio Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Polio Vaccine Revenue Share by Type (2015-2020)
Figure 28. Global Polio Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Polio Vaccine Revenue Share by Application (2015-2020)
Figure 30. Global Polio Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Polio Vaccine Sales Market Share by Type in 2019
Figure 32. United States Polio Vaccine Sales Market Share by Type in 2019
Figure 33. Europe Polio Vaccine Sales Market Share by Company in 2019
Figure 34. Europe Polio Vaccine Sales Market Share by Type in 2019
Figure 35. Europe Polio Vaccine Sales Market Share by Application in 2019
Figure 36. China Polio Vaccine Sales Market Share by Company in 2019
Figure 37. China Polio Vaccine Sales Market Share by Type in 2019
Figure 38. China Polio Vaccine Sales Market Share by Application in 2019
Figure 39. Japan Polio Vaccine Sales Market Share by Company in 2019
Figure 40. Japan Polio Vaccine Sales Market Share by Type in 2019
Figure 41. Japan Polio Vaccine Sales Market Share by Application in 2019
Figure 42. Southeast Asia Polio Vaccine Sales Market Share by Company in 2019
Figure 43. Southeast Asia Polio Vaccine Sales Market Share by Type in 2019
Figure 44. Southeast Asia Polio Vaccine Sales Market Share by Application in 2019
Figure 45. India Polio Vaccine Sales Market Share by Company in 2019
Figure 46. India Polio Vaccine Sales Market Share by Type in 2019
Figure 47. India Polio Vaccine Sales Market Share by Application in 2019
Figure 48. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Bibcol Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Serum Institute Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Tiantan Biological Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. IMBCA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Panacea Biotec Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Bio-Med Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Halfkin Bio-Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Key Raw Materials Price Trend
Figure 58. Manufacturing Cost Structure of Polio Vaccine
Figure 59. Manufacturing Process Analysis of Polio Vaccine
Figure 60. Polio Vaccine Industrial Chain Analysis
Figure 61. Channels of Distribution
Figure 62. Distributors Profiles
Figure 63. Porter's Five Forces Analysis
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
全ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global All Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data i…- ライム病ワクチンの世界市場レポート2020 Market Analysis and Insights: Global Lyme Disease Vaccine Market The global Lyme Disease Vaccine market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Lyme Disease Vaccine Scope and Market Size The global Lyme …
- 多価肺炎球菌ワクチンの世界市場レポート2020 Pneumococcal vaccines are vaccines against the bacteria Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis. Market Analysis and Insights: Global Pneumococcal Vaccine Polyvalent Market The global Pneumococcal Vaccine Polyvalent market was valued at US$ xx …
- 食用ワクチンの世界市場レポート2020 Market Analysis and Insights: Global Edible Vaccine Market The global Edible Vaccine market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Edible Vaccine Scope and Market Size The global Edible Vaccine market i…
- 肺炎球菌ワクチンの世界市場レポート2020 Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40% in 2015. The second place is Europe, following North America with sales market share over 18…